» Articles » PMID: 18394993

Resolution of Sister Centromeres Requires RanBP2-mediated SUMOylation of Topoisomerase IIalpha

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2008 Apr 9
PMID 18394993
Citations 178
Authors
Affiliations
Soon will be listed here.
Abstract

RanBP2 is a nucleoporin with SUMO E3 ligase activity that functions in both nucleocytoplasmic transport and mitosis. However, the biological relevance of RanBP2 and the in vivo targets of its E3 ligase activity are unknown. Here we show that animals with low amounts of RanBP2 develop severe aneuploidy in the absence of overt transport defects. The main chromosome segregation defect in cells from these mice is anaphase-bridge formation. Topoisomerase IIalpha (Topo IIalpha), which decatenates sister centromeres prior to anaphase onset to prevent bridges, fails to accumulate at inner centromeres when RanBP2 levels are low. We find that RanBP2 sumoylates Topo IIalpha in mitosis and that this modification is required for its proper localization to inner centromeres. Furthermore, mice with low amounts of RanBP2 are highly sensitive to tumor formation. Together, these data identify RanBP2 as a chromosomal instability gene that regulates Topo IIalpha by sumoylation and suppresses tumorigenesis.

Citing Articles

Structural basis for a nucleoporin exportin complex between RanBP2, SUMO1-RanGAP1, the E2 Ubc9, Crm1 and the Ran GTPase.

Baytshtok V, DiMattia M, Lima C bioRxiv. 2025; .

PMID: 39763778 PMC: 11703149. DOI: 10.1101/2024.10.04.616749.


DeSUMOylating isopeptidase 1 participates in the faithful chromosome segregation and vincristine sensitivity.

Ikeda Y, Yuki R, Saito Y, Nakayama Y FASEB J. 2024; 38(24):e70261.

PMID: 39698932 PMC: 11656513. DOI: 10.1096/fj.202401560RR.


Tissue adaptation to metabolic stress: insights from SUMOylation.

Xie H, Liu X, Li S, Wang M, Li Y, Chen T Front Endocrinol (Lausanne). 2024; 15:1434338.

PMID: 39588331 PMC: 11586182. DOI: 10.3389/fendo.2024.1434338.


Advances in the understanding of nuclear pore complexes in human diseases.

Li Y, Zhu J, Zhai F, Kong L, Li H, Jin X J Cancer Res Clin Oncol. 2024; 150(7):374.

PMID: 39080077 PMC: 11289042. DOI: 10.1007/s00432-024-05881-5.


Unlocking the Gateway: The Spatio-Temporal Dynamics of the p53 Family Driven by the Nuclear Pores and Its Implication for the Therapeutic Approach in Cancer.

Ikliptikawati D, Makiyama K, Hazawa M, Wong R Int J Mol Sci. 2024; 25(13).

PMID: 39000572 PMC: 11242911. DOI: 10.3390/ijms25137465.


References
1.
Joseph J, Liu S, Jablonski S, Yen T, Dasso M . The RanGAP1-RanBP2 complex is essential for microtubule-kinetochore interactions in vivo. Curr Biol. 2004; 14(7):611-7. DOI: 10.1016/j.cub.2004.03.031. View

2.
Mahajan R, Delphin C, Guan T, Gerace L, Melchior F . A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell. 1997; 88(1):97-107. DOI: 10.1016/s0092-8674(00)81862-0. View

3.
Matunis M, Pickart C . Beginning at the end with SUMO. Nat Struct Mol Biol. 2005; 12(7):565-6. DOI: 10.1038/nsmb0705-565. View

4.
Takahashi Y, Yong-Gonzalez V, Kikuchi Y, Strunnikov A . SIZ1/SIZ2 control of chromosome transmission fidelity is mediated by the sumoylation of topoisomerase II. Genetics. 2005; 172(2):783-94. PMC: 1456244. DOI: 10.1534/genetics.105.047167. View

5.
Beer D, Kardia S, Huang C, Giordano T, Levin A, Misek D . Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 2002; 8(8):816-24. DOI: 10.1038/nm733. View